Matthew Wakefield
Chairman bij OXFORD BIODYNAMICS PLC
Vermogen: 154 435 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Matthew Wakefield
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 12 | |
Collins Stewart Hawkpoint Ltd.
 Collins Stewart Hawkpoint Ltd. Investment Banks/BrokersFinance Collins Stewart Hawkpoint Ltd. provides financial advisory services. Its services include institutional stock broking, fixed income credit trading, corporate broking, corporate finance advisory services, debt capital markets advice, restructuring and debt advisory services, private client and intermediary wealth management, and fund management. The company was founded on May 05, 2006 and is headquartered in London, the United Kingdom.
4
| Subsidiary | Investment Banks/Brokers | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Matthew Wakefield via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| OPGEN, INC. | Miscellaneous Commercial Services | Chief Operating Officer | |
OncoPlex Diagnostics, Inc.
 OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Medical/Nursing Services | Chief Operating Officer Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MID WYND INTERNATIONAL INVESTMENT TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
| University of Oxford | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
MTI Partners Ltd.
 MTI Partners Ltd. Investment ManagersFinance MTI Partners Ltd (MTI Partners) is an independent venture capital firm founded in 1983. The firm is headquartered in UK. | Investment Managers | Private Equity Investor | |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The private company is based in Greenford, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree | |
Trafalgar Ltd
 Trafalgar Ltd Apparel/FootwearConsumer Non-Durables Trafalgar Ltd is a private company that manufactures clothing accessories for men. The company is based in Norwalk, CT and has subsidiaries in Canada. | Apparel/Footwear | Director/Board Member | |
Hunter-Fleming Ltd.
 Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Medical Specialties | Director/Board Member | |
| Georgetown University | College/University | Undergraduate Degree | |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | President | |
TP ICAP Finance Plc
 TP ICAP Finance Plc Finance/Rental/LeasingFinance TP ICAP Finance Plc operates as an intermediary in wholesale financial markets facilitating the trading activities of its clients, in particular commercial and investment banks. It provides voice, hybrid and electronic broking, volume matching, algorithmic matching and risk mitigation platforms. The company's products include volatility, rates, non banking, treasury, energy and commodities, credit and equities. TP ICAP was founded on May 5, 2006 and is headquartered in London, the United Kingdom. | Finance/Rental/Leasing | Chief Executive Officer Corporate Secretary | |
| UNIVERSAL OFFICE AUTOMATION LIMITED | Computer Peripherals | Director/Board Member | |
Tullett Prebon Financial Services LLC
 Tullett Prebon Financial Services LLC Investment Banks/BrokersFinance Founded in 2006, Tullett Prebon Financial Services LLC is a FINRA-registered broker/dealer located in Jersey City, New Jersey. The firm is a subsidiary of Tullett Prebon Americas Corp. and their ultimate parent is Tullett Prebon Plc. Tullett Prebon Financial Services provides a variety of services including floor trading, retailing of corporate equity securities OTC, U.S. Government securities, municipal securities, oil & gas interests, puts & Calls, option writing, private placements and the selling of interest in mortgages or other receivables. Tullett Prebon also acts as a broker on a name give-up bases on transactions involving derivatives, including but not limited to credit derivatives. | Investment Banks/Brokers | Chief Executive Officer | |
Tullett Prebon Americas Corp.
 Tullett Prebon Americas Corp. Investment Banks/BrokersFinance Tullett Prebon Americas Corp. provides security brokerage services. The company is headquartered New Jersey City, NJ. | Investment Banks/Brokers | Chief Executive Officer Chief Executive Officer | |
TP ICAP Global Markets Americas LLC
 TP ICAP Global Markets Americas LLC Investment Banks/BrokersFinance TP ICAP Global Markets Americas LLC (TP ICAP) is registered broker/dealer headquartered in New York City. The firm was founded in 1998 and formerly known as Garban Corporates LLC and as ICAP Corporates LLC. They are a wholly-owned subsidiary of ICAP Securities USA LLC, which is ultimately owned by TP ICAP Group Plc (LON: TCAP) in Great Britain. TP ICAP provides comprehensive analysis and insight into market conditions and long-term trends. They combine data, knowledge and intelligence into contextual insight and commercial guidance. | Investment Banks/Brokers | Chief Executive Officer | |
System Online Ltd.
 System Online Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Smartspace Software Plc, System Online Ltd. is a British company that provides information technology services. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Premium O Ltd.
 Premium O Ltd. Specialty TelecommunicationsCommunications Part of Smartspace Software Plc, Premium O Ltd. is a British telecommunications company. The private company is based in High Wycombe, UK. Premium O was acquired by Smartspace Software Plc on June 12, 2013 for $1.45 million. | Specialty Telecommunications | Director/Board Member | |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Rutherford Health Plc
 Rutherford Health Plc Medical/Nursing ServicesHealth Services Rutherford Health Plc is a holding company, which engages in the provision of cancer treatment research and technology services. It operates oncology centers that offers a range of cancer treatments to patients including radiotherapy, chemotherapy, imaging, and ancillary well-being services. The company was founded by Michael Moran and Karol Sikora on February 4, 2015 and is headquartered in Hereford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
| Sibelius Ltd. | Director/Board Member Director/Board Member | ||
Liver Group Charity
 Liver Group Charity Miscellaneous Commercial ServicesCommercial Services Liver Group Charity operates as a charity. The private company is based in London, UK. | Miscellaneous Commercial Services | Chairman | |
| Plassey Ltd. | Director/Board Member | ||
| Superline Telecommunications Ltd. | Director/Board Member | ||
| Universal Office Automation (Networks) Ltd. | Director/Board Member | ||
| Westminster Capital Partner Ltd. | Director/Board Member | ||
| Sandpiper Resort Ltd. | Director/Board Member | ||
| Monsoon Dune Pvt Ltd. | Director/Board Member | ||
| Monsoon Beach Pvt Ltd. | Director/Board Member | ||
| Kingfisher Villa Pvt Ltd. | Director/Board Member | ||
| 3DM (Asia) Ltd. | Director/Board Member | ||
| TQP Technology Ltd. | Director/Board Member | ||
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| SCHRODER BRITISH OPPORTUNITIES TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
| Excelredstone Comunica Ltd. | Director/Board Member | ||
| WORLDWIDE HEALTHCARE TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 41 |
| Verenigde Staten | 10 |
| India | 2 |
Sectoraal
| Health Technology | 9 |
| Finance | 9 |
| Commercial Services | 7 |
| Miscellaneous | 5 |
| Electronic Technology | 4 |
Operationeel
| Director/Board Member | 101 |
| Corporate Officer/Principal | 21 |
| Chief Executive Officer | 17 |
| Chairman | 12 |
| Independent Dir/Board Member | 11 |
Sterkste connecties
| Insiders | |
|---|---|
| Diana Bartlett | 40 |
| Stephen Diggle | 32 |
| David Holbrook | 23 |
| Christian Millar | 16 |
| Terry Smith | 14 |
| Peter Pack | 8 |
| John J. Abularrage | 7 |
| Jon Burrows | 7 |
| Paul M. Baines | 6 |
| Alexandre Akoulitchev | 6 |
| Ewan Hunter | 6 |
| Thomas Guiel | 4 |
| Paul Stockdale | 4 |
| Bartu Ahiska | 4 |
| Aroul Ramadass | 1 |
- Beurs
- Insiders
- Matthew Wakefield
- Bedrijfsconnecties
